Cargando…

Serum lnc34a is a potential prediction biomarker for bone metastasis in hepatocellular carcinoma patients

BACKGROUND: Early screening and intervention therapies are crucial to improve the prognosis of hepatocellular carcinoma (HCC) patients with bone metastasis. We aimed to identify serum lncRNA as a prediction biomarker in HCC bone metastasis. METHODS: The expression levels of lnc34a in serum samples f...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhang, Li, Niu, Hao, Yang, Ping, Ma, Jie, Yuan, Bao-Ying, Zeng, Zhao-Chong, Xiang, Zuo-Lin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2021
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7885499/ https://www.ncbi.nlm.nih.gov/pubmed/33588789 http://dx.doi.org/10.1186/s12885-021-07808-6

Ejemplares similares

The molecular mechanism of LncRNA34a-mediated regulation of bone metastasis in hepatocellular carcinoma
por: Zhang, Li, et al.
Publicado: (2019)

MicroRNA-34a expression levels in serum and intratumoral tissue can predict bone metastasis in patients with hepatocellular carcinoma
por: Xiang, Zuo-Lin, et al.
Publicado: (2016)

Correction: MicroRNA-34a expression levels in serum and intratumoral tissue can predict bone metastasis in patients with hepatocellular carcinoma
por: Xiang, Zuo-Lin, et al.
Publicado: (2019)

A Noninvasive Prediction Nomogram for Lymph Node Metastasis of Hepatocellular Carcinoma Based on Serum Long Noncoding RNAs
por: Ma, Jie, et al.
Publicado: (2019)

lncRNA involvement in hepatocellular carcinoma metastasis and prognosis
por: Abbastabar, Maryam, et al.
Publicado: (2018)

Serum LncRNAs Profiles Serve as Novel Potential Biomarkers for the Diagnosis of HBV-Positive Hepatocellular Carcinoma
por: Wang, Kang, et al.
Publicado: (2015)

LncRNA AY promotes hepatocellular carcinoma metastasis by stimulating ITGAV transcription
por: Kang, Chun Lan, et al.
Publicado: (2019)

A nomogram to predict prognosis of patients with unresected hepatocellular carcinoma undergoing radiotherapy: a population-based study
por: Zhang, Li, et al.
Publicado: (2019)

Serum exosomal long noncoding RNAs lnc-FAM72D-3 and lnc-EPC1-4 as diagnostic biomarkers for hepatocellular carcinoma
por: Yao, Zhicheng, et al.
Publicado: (2020)

Serum exosomal miR-34a as a potential biomarker for the diagnosis and prognostic of hepatocellular carcinoma
por: Chen, Shuying, et al.
Publicado: (2022)

A microRNA-based prediction model for lymph node metastasis in hepatocellular carcinoma
por: Zhang, Li, et al.
Publicado: (2015)

Up-Regulated CCDC34 Contributes to the Proliferation and Metastasis of Hepatocellular Carcinoma
por: Lin, Zhibin, et al.
Publicado: (2020)

Emerging Perspectives of Bone Metastasis in Hepatocellular Carcinoma
por: Yuan, Xiaofeng, et al.
Publicado: (2022)

N(6)-Methyladenosine Modification of ANLN Enhances Hepatocellular Carcinoma Bone Metastasis
por: Zheng, Hao, et al.
Publicado: (2023)

Serum-Derived Exosomal Proteins as Potential Candidate Biomarkers for Hepatocellular Carcinoma
por: Zhao, Liping, et al.
Publicado: (2021)

Identification of a Prognostic Transcriptome Signature for Hepatocellular Carcinoma with Lymph Node Metastasis
por: Ma, Jie, et al.
Publicado: (2022)

IL-32 and IL-34 in hepatocellular carcinoma
por: Si, Yang, et al.
Publicado: (2022)

LncRNA SUMO1P3 acts as a prognostic biomarker and promotes hepatocellular carcinoma growth and metastasis
por: Hu, Shu, et al.
Publicado: (2021)

Serum Biomarkers for the Prediction of Hepatocellular Carcinoma
por: Debes, José D., et al.
Publicado: (2021)

Alcohol and hepatitis virus-dysregulated lncRNAs as potential biomarkers for hepatocellular carcinoma
por: Zheng, Hao, et al.
Publicado: (2017)

LncRNA UCID Promotes Hepatocellular Carcinoma Metastasis via Stabilization of Snail
por: Yuan, Shanshan, et al.
Publicado: (2021)

LncRNA PTPRG-AS1 Promotes the Metastasis of Hepatocellular Carcinoma by Enhancing YWHAG
por: Chen, Gaoyang, et al.
Publicado: (2021)

Chemokine receptor CXCR4 expression in hepatocellular carcinoma patients increases the risk of bone metastases and poor survival
por: Xiang, Zuo-lin, et al.
Publicado: (2009)

Serum/Plasma MicroRNAs as Biomarkers for HBV-Related Hepatocellular Carcinoma in China
por: Yin, Wen, et al.
Publicado: (2015)

Circulating miR-21 serves as a serum biomarker for hepatocellular carcinoma and correlated with distant metastasis
por: Guo, Xin, et al.
Publicado: (2017)

NOL12 as an Oncogenic Biomarker Promotes Hepatocellular Carcinoma Growth and Metastasis
por: Huang, Jianfeng, et al.
Publicado: (2022)

Integrative analysis of dysregulated lncRNA-associated ceRNA network reveals potential lncRNA biomarkers for human hepatocellular carcinoma
por: Li, Chengyun, et al.
Publicado: (2020)

Isolated metastasis of hepatocellular carcinoma in the right ventricle
por: Zhang, Xin-tong, et al.
Publicado: (2019)

Tissue- and Serum-Associated Biomarkers of Hepatocellular Carcinoma
por: Chauhan, Ranjit, et al.
Publicado: (2016)

Diagnostic and prognostic nomograms for bone metastasis in hepatocellular carcinoma
por: Hu, Chuan, et al.
Publicado: (2020)

Galectin-4 serves as a prognostic biomarker for the early recurrence / metastasis of hepatocellular carcinoma
por: Cai, Zhixiong, et al.
Publicado: (2014)

Identification of lncRNA biomarkers in hepatocellular carcinoma by comprehensive analysis of the lncRNA-mediated ceRNA network
por: Ye, Dingde, et al.
Publicado: (2022)

Serum PON1 as a biomarker for the estimation of microvascular invasion in hepatocellular carcinoma
por: Ding, Guang-Yu, et al.
Publicado: (2020)

Diagnostic Value of lncRNAs as Biomarker in Hepatocellular Carcinoma: An Updated Meta-Analysis
por: Chen, Shilian, et al.
Publicado: (2018)

Lnc-PCDH9-13:1 Is a Hypersensitive and Specific Biomarker for Early Hepatocellular Carcinoma
por: Xie, Zijun, et al.
Publicado: (2018)

Macrophage polarization-associated lnc-Ma301 interacts with caprin-1 to inhibit hepatocellular carcinoma metastasis through the Akt/Erk1 pathway
por: Luo, Hong-Lin, et al.
Publicado: (2021)

Can Serum Glypican-3 Be a Biomarker for Effective Diagnosis of Hepatocellular Carcinoma? A Meta-Analysis of the Literature
por: Yang, Sheng-Li, et al.
Publicado: (2014)

Expression Analysis of Serum microRNA-34a and microRNA-183 in Hepatocellular Carcinoma
por: Bharali, Dipu, et al.
Publicado: (2018)

LncSHRG promotes hepatocellular carcinoma progression by activating HES6
por: Xu, Ying-Chen, et al.
Publicado: (2017)

A novel immune-related genes prognosis biomarker for hepatocellular carcinoma
por: Wang, Kunpeng, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_rmao0u9cia3rfmg0lk0dlf7fg1